A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650

Completed · Phase 3 · Has a placebo group

Conditions studied: Type 2 Diabetes

In brief

Phase 3 study to Evaluate cardiovascular outcomes in patients with type 2 diabetes treated with ITCA 650.

Key facts

Study ID
NCT01455896
Run by
Intarcia Therapeutics
People needed
4156
Starts
2013-03-01
Expected to finish
2016-03-01
Last updated by the study team
2017-01-27

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.